|
|
|
| home > white papers > Tightening Your Supply Chain Against Counterfeits - World Courier |
|
|
 WHITE PAPERS |
|
World Courier
|
|
Tightening Your Supply Chain Against Counterfeits
|
|
As today’s global pharmaceutical supply chain grows increasingly longer and more complex, each link provides added opportunity for counterfeiters.
While pending regulatory changes promise to tighten the supply chain with respect to production and distribution entities and new packaging technologies will make the identification of counterfeit products easier, the logistics of global distribution remains a weak link.
How can the pharmaceutical shipper ensure the security of the supply chain over thousands of miles and extended periods of time when the product is no longer in his possession?
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Get on Board with a Neat Idea
Teknomek has launched a new range of anti-microbial shadow boards developed to meet the specific needs of the pharma sector. The products are made from PVC infused with Biomaster anti-bacterial silver-ion technology, which inhibits the growth of bacteria by up to 99.9%.
More info >> |
|
 |
White Papers |
 |
|
Blockbuster Drugs Need Blockbuster Components
West Pharmaceutical Services, Inc.
Many of the world’s blockbuster drugs are now delivered via a prefilled syringe system or auto-injector. To ensure patient safety, pharmaceutical manufacturers need high-quality components that feature reduced particulates and ensure consistency of delivery while fitting the changing needs of higher-volume delivery systems.
More info >> |
|
 |
Industry Events |
 |
SCOPE Europe: Summit for Clinical Ops Executives
16-17 October 2018, Barcelona, Spain
Building on the
success of its long-running US-based counterpart, Summit for Clinical Trials
Operations Executives Europe (SCOPE Europe) is a two-day event serving clin ops
execs, functional heads, category managers and those responsible for the
planning and management of clinical trials in Europe and the Rest of the World.
More info >> |
|
|
|
